Purchases and Sales Made in Q4 2023 in Evaxion Biotech A/S (EVAX)
This table provides information about the institutional ownership of Evaxion Biotech A/S (EVAX) during Q4 2023. The information is specifically focused on institutions that hold shares of Evaxion Biotech A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Lm Advisors LLC
San Diego, CA |
BUY
|
- |
337KNew |
$202K - $395K
|
337K
$287K
|
|
|
Jan 09, 2024
Q4 2023
|
Beacon Capital Management, LLC
|
BUY
|
- |
41.8K+ 606.77% |
$25.1K - $48.8K
|
48.6K
$41.3K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
24.6KNew |
$14.8K - $28.8K
|
24.6K
$20.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
14KNew |
$8.4K - $16.4K
|
14K
$11.9K
|
|
|
Feb 08, 2024
Q4 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
800+ 37.93% |
$480 - $936
|
2.91K
$2.47K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-286- 3.08% |
$172 - $335
|
9K
$7.65K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-3.73K- 93.08% |
$2.24K - $4.36K
|
277
$235
|